Nasdaq:US$14.83 (+0.07) | HKEX:HK$23.42 (+0.20) | AIM:£2.27 (+0)
搜索結果
上一篇文章   |   下一篇文章
公告及新聞稿, 腫瘤學 / 免疫學 | 2006-07-04

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate